New Key Statistics Module, Z-Score and F-Score
OTCPK:KBYPF Key Ratios
Market Cap $ M | 2,757.98 |
Enterprise Value $ M | 2,352.92 |
P/E(ttm) | 29.46 |
PE Ratio without NRI | 21.34 |
Forward PE Ratio | 23.66 |
Price/Book | 1.92 |
Price/Sales | 2.35 |
Price/Free Cash Flow | 85.86 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,160.00 |
EPS (TTM) $ | 1.25 |
Beneish M-Score | -2.25 |
10-y EBITDA Growth Rate % | 6.00 |
5-y EBITDA Growth Rate % | 3.90 |
y-y EBITDA Growth Rate % | -32.40 |
EV-to-EBIT | 18.31 |
EV-to-EBITDA | 18.31 |
PEG | 5.47 |
Shares Outstanding M | 74.34 |
Net Margin (%) | 8.04 |
Operating Margin % | 14.37 |
Pre-tax Margin (%) | 10.84 |
Quick Ratio | 2.21 |
Current Ratio | 2.88 |
ROA % (ttm) | 5.24 |
ROE % (ttm) | 6.67 |
ROIC % (ttm) | 12.09 |
Dividend Yield % | -- |
Altman Z-Score | 6.98 |
KBYPF Number of Guru Trades
KBYPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:KBYPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:KBYPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kobayashi Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:KBYPF
Total 0- 1